Optimizing colistin dosing in patients undergoing continuous kidney replacement therapy: critical considerations for intensivists.
作者信息
Honore Patrick M, Perriens Emily, Blackman Sydney, De Lissnyder Nathan, Detournay Anaëlle, Cutuli Salvatore Lucio, De Pascale Gennaro, Mariano Filippo
机构信息
CHU UCL Godinne Namur, UCL Louvain Medical School, Campus Godinne, Avenue G Thérasse 1, 5530, Yvoir (Namur), Belgium.
Faculty of Medicine and member of the Experimental Research Laboratory Institute of the Catholic Louvain Medical School, Brussels, Belgium.
出版信息
Crit Care. 2025 May 8;29(1):184. doi: 10.1186/s13054-025-05412-9.
Abstract
摘要
相似文献
1
Optimizing colistin dosing in patients undergoing continuous kidney replacement therapy: critical considerations for intensivists.优化接受持续肾脏替代治疗患者的黏菌素剂量：重症监护医生的关键考量因素
Crit Care. 2025 May 8;29(1):184. doi: 10.1186/s13054-025-05412-9.
2
Colistin Use in Patients With Reduced Kidney Function.多黏菌素在肾功能减退患者中的应用。
Am J Kidney Dis. 2016 Aug;68(2):296-306. doi: 10.1053/j.ajkd.2016.03.421. Epub 2016 May 6.
3
Intravenous colistin in the treatment of multidrug-resistant gram-negative organism in tertiary hospital, Jazan, KSA.沙特阿拉伯王国吉赞市一家三级医院使用静脉注射多黏菌素治疗多重耐药革兰氏阴性菌感染
J Family Med Prim Care. 2021 Jan;10(1):333-338. doi: 10.4103/jfmpc.jfmpc_1148_20. Epub 2021 Jan 30.
4
Population pharmacokinetics of piperacillin in critically ill children including those undergoing continuous kidney replacement therapy.哌拉西林在危重症儿童中的群体药代动力学研究，包括正在接受连续肾脏替代治疗的患儿。
Clin Microbiol Infect. 2022 Sep;28(9):1287.e9-1287.e15. doi: 10.1016/j.cmi.2022.03.031. Epub 2022 Apr 4.
5
Low-Dose Continuous Kidney Replacement Therapy and Mortality in Critically Ill Patients With Acute Kidney Injury: A Retrospective Cohort Study.低剂量连续性肾脏替代治疗与急性肾损伤危重症患者的死亡率：一项回顾性队列研究。
Am J Kidney Dis. 2024 Aug;84(2):145-153.e1. doi: 10.1053/j.ajkd.2024.01.526. Epub 2024 Mar 13.
6
Medication patterns and dosing guidance in pediatric patients supported with intermittent hemodialysis or continuous kidney replacement therapy.接受间歇性血液透析或连续性肾脏替代治疗的儿科患者的用药模式及给药指导。
Pediatr Nephrol. 2024 May;39(5):1521-1532. doi: 10.1007/s00467-023-06199-z. Epub 2023 Dec 5.
7
Safety and efficacy of intravenous colistin (colistin methanesulphonate) for severe multidrug-resistant Gram-negative bacterial infections.静脉注射黏菌素（黏菌素甲磺酸盐）治疗严重多重耐药革兰氏阴性细菌感染的安全性和疗效。
Int J Antimicrob Agents. 2010 Mar;35(3):297-300. doi: 10.1016/j.ijantimicag.2009.11.016. Epub 2009 Dec 31.
8
In vivo evaluation of nephrotoxicity and neurotoxicity of colistin formulated with sodium deoxycholate sulfate in a mice model.在小鼠模型中对用脱氧胆酸钠硫酸盐配制的多粘菌素的肾毒性和神经毒性进行体内评估。
Naunyn Schmiedebergs Arch Pharmacol. 2023 Nov;396(11):3243-3252. doi: 10.1007/s00210-023-02531-4. Epub 2023 May 30.
9
Intravenous colistin for the management of multidrug-resistant bacterial infections in Indian patients.静脉注射黏菌素治疗印度患者的多重耐药菌感染。
Trop Doct. 2021 Jul;51(3):301-306. doi: 10.1177/0049475520987777. Epub 2021 Jan 24.
10
Colistin nephrotoxicity in critically ill patients after implementation of a new dosing strategy.实施新给药策略后重症患者的黏菌素肾毒性
J Infect Dev Ctries. 2019 Oct 31;13(10):877-885. doi: 10.3855/jidc.11413.
本文引用的文献
1
High-dose colistin pharmacokinetics in critically ill patients receiving continuous renal replacement therapy.接受连续性肾脏替代治疗的重症患者的大剂量黏菌素药代动力学
Ann Intensive Care. 2024 Sep 28;14(1):152. doi: 10.1186/s13613-024-01384-1.
2
Antimicrobial Exposure in Critically Ill Patients with Sepsis-Associated Multi-Organ Dysfunction Requiring Extracorporeal Organ Support: A Narrative Review.需要体外器官支持的脓毒症相关多器官功能障碍重症患者的抗菌药物暴露：一项叙述性综述
Microorganisms. 2023 Feb 13;11(2):473. doi: 10.3390/microorganisms11020473.
3
Use of High-Dose Nebulized Colistimethate in Patients with Colistin-Only Susceptible VAP: Clinical, Pharmacokinetic and Microbiome Features.大剂量雾化多粘菌素甲磺酸钠在仅对多粘菌素敏感的呼吸机相关性肺炎患者中的应用：临床、药代动力学和微生物组特征
Antibiotics (Basel). 2023 Jan 9;12(1):125. doi: 10.3390/antibiotics12010125.
4
Colistin: from the shadows to a One Health approach for addressing antimicrobial resistance.黏菌素：从幕后走向一体化健康方法应对抗微生物药物耐药性。
Int J Antimicrob Agents. 2023 Feb;61(2):106713. doi: 10.1016/j.ijantimicag.2023.106713. Epub 2023 Jan 11.
5
Colistin Therapy, Survival and Renal Replacement Therapy in Burn Patients: A 10-Year Single-Center Cohort Study.烧伤患者的黏菌素治疗、生存率及肾脏替代治疗：一项为期10年的单中心队列研究
Int J Gen Med. 2022 May 25;15:5211-5221. doi: 10.2147/IJGM.S357427. eCollection 2022.
6
Clinical use of intravenous polymyxin B for the treatment of patients with multidrug-resistant Gram-negative bacterial infections: An evaluation of the current evidence.静脉注射多黏菌素 B 在治疗多重耐药革兰氏阴性菌感染患者中的临床应用：对现有证据的评估。
J Glob Antimicrob Resist. 2021 Mar;24:342-359. doi: 10.1016/j.jgar.2020.12.026. Epub 2021 Jan 21.
7
Treatment of Ventilator-associated Pneumonia with High-dose Colistin Under Continuous Veno-venous Hemofiltration.在持续静脉-静脉血液滤过下使用大剂量黏菌素治疗呼吸机相关性肺炎
J Transl Int Med. 2019 Oct 12;7(3):100-105. doi: 10.2478/jtim-2019-0022. eCollection 2019 Sep.
8
Towards Understanding MCR-like Colistin Resistance.探索 MCR 样多粘菌素耐药性。
Trends Microbiol. 2018 Sep;26(9):794-808. doi: 10.1016/j.tim.2018.02.006. Epub 2018 Mar 7.
9
Clinical Pharmacokinetics and Pharmacodynamics of Colistin.多黏菌素的临床药代动力学和药效学。
Clin Pharmacokinet. 2017 Dec;56(12):1441-1460. doi: 10.1007/s40262-017-0561-1.
10
Extended-spectrum β-lactamases, carbapenemases and the mcr-1 gene: is there a historical link?超广谱β-内酰胺酶、碳青霉烯酶和 mcr-1 基因：它们之间存在历史关联吗？
Int J Antimicrob Agents. 2017 Mar;49(3):269-271. doi: 10.1016/j.ijantimicag.2016.11.026. Epub 2017 Feb 1.
Zotero 插件